Fig. 3. Forest plot comparing proton pump inhibitor (PPI) plus prokinetics and PPI monotherapy in patients with gastroesophageal reflux disease in term of symptom improvement, subgrouped by refractoriness of gastroesophageal reflux disease.

J Neurogastroenterol Motil 2021;27:165~175 https://doi.org/10.5056/jnm20161

© J Neurogastroenterol Motil